OEC signs fluoroscope deal with Genzyme:
This article was originally published in Clinica
Genzyme of Cambridge, Massachusetts, and OEC Medical Systems of Salt Lake City, Utah, have reached an agreement for OEC to supply its Series 9600 cardiac mobile fluoroscope systems to Genzyme's cardiovascular units. At the same time the companies will now co-market their respective technologies in minimally-invasive cardiovascular surgery, through combined sales and training materials.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.